Biological markers in primary and secondary lymphedema
Part of Blood & lymphatic clinical trials.
This study looks at blood and skin samples from people with lymphedema (a condition causing arm or leg swelling) and healthy volunteers to find markers that might explain why it develops or worsens. It is a single visit for blood and skin swab collection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You may have primary lymphedema (swelling that you were born with or developed without a known cause) or secondary lymphedema (swelling due to another condition, like cancer treatment).
- If you have lymphedema, it should be at an early stage (Stage I or II). If it's Stage III, you may still qualify if you have had repeated skin infections.
- If you are a healthy volunteer, you must have no signs or history of lymphedema.
- You must not have other causes of limb swelling (like heart or kidney disease), a recent serious infection, active cancer treatment, or be a current smoker.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects samples (like blood and possibly lymph fluid-related tests) to help doctors better tailor treatment for lymphedema. It may help researchers find ways to improve outcomes for people treated for swollen, fluid-rich tissue.
This study looks at the bacteria in your gut and how they relate to lymphedema (swelling) and repeated skin infections in the affected limb. It compares people who have many infections with those who have none, to better understand why some get infections and others don't.
This trial looks at factors that affect study experiences for adults with lymphedema, including how they cope with scheduled visits and treatment during the study. It may help researchers improve how future lymphedema studies are run.
This study looks at lymphatic “drainage” problems (lymphedema) and how they develop after breast cancer treatment. It may help doctors better understand lymphedema and improve care for people who meet the study safety requirements.
This trial is developing a tool to screen for, diagnose, and evaluate lower-limb lymphedema (leg swelling caused by lymph fluid). It may help patients get a more accurate diagnosis and better monitoring of their condition.
This study uses special ultrasound techniques to help doctors tell the difference between lymphedema (fluid swelling) and lipedema (fat swelling) in the legs. If you have one of these conditions or have healthy legs, you may be able to join.
Hear when a new Primary Lymphedema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.